CJM Wealth Advisers Ltd. Has $1.68 Million Stake in The Procter & Gamble Company (NYSE:PG)

CJM Wealth Advisers Ltd. lowered its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 5.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,999 shares of the company’s stock after selling 592 shares during the quarter. Procter & Gamble accounts for about 0.6% of CJM Wealth Advisers Ltd.’s portfolio, making the stock its 18th biggest position. CJM Wealth Advisers Ltd.’s holdings in Procter & Gamble were worth $1,676,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of PG. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble in the second quarter valued at about $28,000. Fairway Wealth LLC bought a new stake in Procter & Gamble in the 2nd quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC bought a new stake in Procter & Gamble in the 3rd quarter valued at approximately $33,000. Quest Partners LLC bought a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $36,000. Finally, Fairfield Financial Advisors LTD bought a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $44,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Procter & Gamble

In related news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of Procter & Gamble stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. This trade represents a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 75,439 shares of company stock worth $13,317,460. Company insiders own 0.18% of the company’s stock.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $162.07 on Friday. The company has a market capitalization of $381.68 billion, a PE ratio of 27.94, a P/E/G ratio of 3.70 and a beta of 0.45. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a 50-day moving average price of $169.77 and a two-hundred day moving average price of $169.64. The Procter & Gamble Company has a 12 month low of $146.28 and a 12 month high of $180.43.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.83 earnings per share. Analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research report on Monday, September 30th. Evercore ISI raised their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research report on Monday, October 21st. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, JPMorgan Chase & Co. raised their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $179.75.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.